Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,023 public trials 2,559 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

NCT03151629

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Alabama-Birmingham Birmingham, Alabama, United States
  • University of Alabama- Tuscaloosa Tuscaloosa, Alabama, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • University of California San Diego San Diego, California, United States
View all 121 locations
View Trial Details
Recruiting

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

NCT06386146

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Research Site Denver, Colorado, United States
  • Research site Lake Mary, Florida, United States
  • Research site St Louis, Missouri, United States
  • Research site Canton, Ohio, United States
View all 15 locations
View Trial Details
Recruiting

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

NCT07334119

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +47 more
Locations
  • The Kinghorn Cancer Centre Darlinghurst, New South Wales, Australia
  • Scientia Clinical Research Ltd Randwick, New South Wales, Australia
  • Calvary Mater Newcastle Waratah, New South Wales, Australia
  • Icon Cancer Centre South Brisbane South Brisbane, Queensland, Australia
View Trial Details
Recruiting

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

NCT06053658

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope Irvine, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery

NCT06504147

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • UZ Leuven Leuven, Belgium
  • Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy
  • The Norwegian Radiumhospital Oslo, Norway
View Trial Details

Related conditions